Merck seeks FDA approval for cancer vaccine
Merck has submitted its license application for Gardasil as a vaccine to protect against four types of human papillomavirus (HPV), the sexually transmitted virus responsible for the majority
Teva Pharmaceuticals International has made a bid to acquire a range of neuroscience assets from BioXcel Therapeutics for a total deal value of $125m.